Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUARTET trial in hypertension
ACTRN12616001144404Phase 3Completed
- Sponsor
- The University of Sydney
- Start
- Jun 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of irbesartan, amlodipine, indapamide and bisoprolol in hypertension (HTN), sponsored by The University of Sydney. Primary endpoint: Mean automated office systolic blood pressure. Started Jun 2017; status: completed.
02
Drugs
irbesartanamlodipineindapamidebisoprolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ACTRN12616001144404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001144404.